Lose Weight.
Tirzepatide has demonstrated meaningful weight reduction in clinical studies of approved medicines.

*Totals assume all scheduled payments are completed and exclude any applicable shipping and tax. Monthly plans end after 4 or 6 payments, including the first. Future renewals can be cancelled.
Selected: One-time purchase
One vial per month. The plan ends after all 4 or 6 monthly payments.
Online payment is currently unavailable.
Read product information →
Illustrative imagery · Not actual ALUNEVIA patient resultsTirzepatide has demonstrated meaningful weight reduction in clinical studies of approved medicines.
GLP-1 and GIP receptor activity can help regulate appetite and food intake.
Work toward a more active and confident lifestyle with a medically supervised plan.
ALUNEVIA is labeled as (tirzepatide) injection. The presentation shown here is a single-dose vial containing 10 mg / 2 mL (5 mg/mL), supplied in an outer carton.
The carton is labeled as containing one single-dose vial of 10 mg / 2 mL. Needles and syringes are not included.
The packaging states: store refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze. Protect from light. Keep out of reach of children.

Illustrative kit concept. The current carton contains one vial; needles and syringes are not included.